A recently approved drug for malaria treatment offers hope to millions of children who suffer from the disease in Africa.
Articles on Insecticide-treated bed nets
Displaying all articles
There are many reasons that malaria is so persistent in Africa. Four of them are poverty, human movement, resistance and climate change.
Artificial lights could trick malaria-transmitting mosquito species that feed nocturnally into behaving as if it’s daytime.
Like the coronavirus causing the current pandemic, both the malaria parasite and mosquito vector are developing ways to avoid control.
We’ve made advances towards delivering new devices to empower even people with basic medical knowledge to administer malaria tests in the field.
This project may help to eradicate malaria by developing new technologies to prevent mosquitoes from biting people when they are outdoors.
If not addressed, there will be many more deaths from malaria and other diseases, indirectly linked to COVID-19 disruptions.
When there are two malaria prevention interventions available people don’t take an either or approach – they consider that the two interventions are complementary.
Epidemiologists and public health managers are looking to complement indoor-based malaria solutions with those that focus on the outdoors. Drones are a crucial part of their armoury.
A spike in the number of malaria cases in southern Africa means that the region will not meet its initial target of eliminating malaria by 2018.
Eliminating malaria in Africa has been held back by a range of factors, including a lack of funds and drug and insecticide resistance challenges.
Bednet insecticides should kill mosquitoes on contact, but some have become highly resistant to the chemicals.
They not only bear the heaviest burden of malaria on the continent: Nigerians are also paying the most for services related to the disease.
Top contributors
-
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
-
Laboratory Manager/PhD student
-
Research fellow, University of Glasgow
-
Professor of Health Economics and Policy and Pharmaco-economics/pharmaco-epidemiology in the Departments of Health Administration & Management and Pharmacology and Therapeutics, College of Medicine, University of Nigeria
-
Wolfson Chair of Bioengineering (Biomedical Engineering), University of Glasgow
-
Country Director I-TECH Kenya, University of Washington
-
Postdoctoral Researcher, University of South Florida
-
Director of Science, Ifakara Health Institute
-
Senior lecturer, University of Pretoria
-
Chercheuse en sciences sociales au CNRS, Paris School of Economics – École d'économie de Paris
-
Professor in the Department of Economics, University of South Florida
-
Unit Director of the Office of Malaria Research , South African Medical Research Council
-
Medical scientist, National Institute for Communicable Diseases
-
Postdoctoral fellow in UP Institute for Sustainable Malaria Control (UP ISMC), University of Pretoria
-
Reader (Biomedical Engineering), University of Glasgow